Does TENAPANOR Cause Therapy cessation? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Therapy cessation have been filed in association with TENAPANOR (IBSRELA). This represents 0.3% of all adverse event reports for TENAPANOR.
5
Reports of Therapy cessation with TENAPANOR
0.3%
of all TENAPANOR reports
0
Deaths
2
Hospitalizations
How Dangerous Is Therapy cessation From TENAPANOR?
Of the 5 reports, 2 (40.0%) required hospitalization.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TENAPANOR. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does TENAPANOR Cause?
Diarrhoea (793)
Death (222)
Hospitalisation (138)
Inappropriate schedule of product administration (115)
Off label use (94)
Product use issue (72)
Nausea (59)
Abdominal distension (52)
Therapy interrupted (52)
Abdominal pain (50)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which TENAPANOR Alternatives Have Lower Therapy cessation Risk?
TENAPANOR vs TENECTEPLASE
TENAPANOR vs TENELIGLIPTIN
TENAPANOR vs TENIPOSIDE
TENAPANOR vs TENOFOVIR
TENAPANOR vs TENOFOVIR ALAFENAMIDE